1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Hepatocellular Carcinoma: Executive Summary
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Reports

3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.4.3 Diagnosed Incident Cases of HCC
3.4.4 Diagnosed Incident Cases of HCC by BCLC Stage
3.4.5 Diagnosed Incident Cases of HCC by Child Pugh Stage
3.4.6 Diagnosed Incident Cases by HCC Risk Factors
3.4.7 Diagnosed Incident Cases of HCC by Cirrhotic Versus Non-cirrhotic HCC
3.4.8 Diagnosed Incident Cases of HCC by Biomarker AFP
3.4.9 Five-Year Diagnosed Prevalent Cases of HCC
3.4.10 All-Time Diagnosed Prevalent Cases of BCLC by Stage
3.5 Epidemiological Forecast for HCC, 2019-2029
3.5.1 Diagnosed Incident Cases of HCC
3.5.2 Sex-Specific Diagnosed Incident Cases of HCC
3.5.3 Age-Specific Diagnosed Incident Cases of HCC
3.5.4 Diagnosed Incident Cases of HCC by BCLC Stage
3.5.5 Diagnosed Incident Cases of HCC by Child Pugh Stage
3.5.6 Diagnosed Incident Cases of HCC by Risk Factors
3.5.7 Diagnosed Incident Cases by Cirrhotic Versus Non-cirrhotic HCC
3.5.8 Diagnosed Incident Cases of HCC by Biomarker AFP
3.5.9 Five-Year Diagnosed Prevalent Cases of HCC
3.5.10 All-Time Diagnosed Prevalent Cases of HCC by BCLC Stage
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 COVID-19 Impact
3.6.3 Limitations of the Analysis
3.6.4 Strengths of the Analysis

4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer

List of Tables
Table 1: Summary of Newly Added Data Types and Countries
Table 2: Summary of Updated Data Types
Table 3: Risk Factors and Comorbidities for HCC

List of Figures
Figure 1: 8MM, Diagnosed Incident Cases of HCC (N), Both Sexes, Ages ?18 Years, 2019 and 2029
Figure 2: 8MM, Five-Year Diagnosed Prevalent Cases of HCC (N), Both Sexes, Ages ?18 Years, 2019 and 2029
Figure 3: 8MM, Diagnosed Incidence of HCC (Cases per 100,000 Population), Men, Ages ?18 Years, 2009-2029
Figure 4: 8MM, Diagnosed Incidence of HCC (Cases per 100,000 Population), Women, Ages ?18 Years, 2009-2029
Figure 5: 8MM, Sources Used and Not Used to Forecast the Diagnosed Incident Cases of HCC
Figure 6: 8MM, Sources Used to Forecast the Diagnosed Incident Cases of HCC by BCLC Stage
Figure 7: 8MM, Sources Used to Forecast the Diagnosed Incident Cases of HCC by Child Pugh Stage
Figure 8: 8MM, Sources Used to Forecast the Diagnosed Incident Cases by HCC Risk Factors (HBV and HCV)
Figure 9: 8MM, Sources Used to Forecast the Diagnosed Incident Cases by HCC Risk Factors (NASH/NAFLD)
Figure 10: 8MM, Sources Used to Forecast the Diagnosed Incident Cases by HCC Risk Factors (Alcohol Use)
Figure 11: 8MM, Sources Used to Forecast the Diagnosed Incident Cases by Cirrhotic versus Non-Cirrhotic HCC
Figure 12: 8MM, Sources Used to Forecast the Diagnosed Incident Cases of HCC by Biomarker AFP
Figure 13: 8MM, Sources Used to Forecast the Five-Year Diagnosed Prevalent Cases of HCC
Figure 14: 8MM, Sources Used to Forecast the All-Time Diagnosed Prevalent Cases of HCC by BCLC Stage
Figure 15: 8MM, Diagnosed Incident Cases of HCC, Both Sexes, Ages ?18 Years, N, 2019
Figure 16: 8MM, Diagnosed Incident Cases of HCC, by Sex, Ages ?18 Years, N, 2019
Figure 17: 8MM, Diagnosed Incident Cases of HCC by Age, Both Sexes, N, 2019
Figure 18: 8MM, Diagnosed Incident Cases of HCC by BCLC Stage, Both Sexes, Ages ?18 Years, N, 2019
Figure 19: 8MM, Diagnosed Incident Cases of HCC by Child Pugh Stage, Both Sexes, Ages ?18 Years, N, 2019
Figure 20: 8MMM, Diagnosed Incident Cases by HCC by HCC Risk Factors, Both Sexes, Ages ?18 Years, N, 2019
Figure 21: 8MM, Diagnosed Incident Cases by Cirrhotic versus Non-Cirrhotic HCC, Both Sexes, Ages ?18 Years, N, 2019
Figure 22: 8MM, Diagnosed Incident Cases of HCC by Biomarker AFP, Both Sexes, Ages ?18 Years, N, 2019
Figure 23: 8MM, Five-Year Diagnosed Prevalent Cases of HCC, Both Sexes, Ages ?18 Years, N, 2019
Figure 24: 8MM, All-Time Diagnosed Prevalent Cases of HCC by BCLC Stage, Both Sexes, Ages ?18 Years, N, 2019